{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:01:59Z","timestamp":1793311319192,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.neuropharm.2019.107900","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T22:39:13Z","timestamp":1575499153000},"page":"107900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-6222","authenticated-orcid":false,"given":"Rania M.","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada A.","family":"Abdel-Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah S.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hekmat M.","family":"El Magdoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona F.","family":"Schaalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107900_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbr.2003.12.021","article-title":"L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats","volume":"153","author":"Alam","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib3","first-page":"101","article-title":"Sample size calculation in animal studies using resource equation Approach","volume":"24","author":"Arifin","year":"2017","journal-title":"Malays. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2019.107900_bib4","first-page":"493","article-title":"Protective effects of crocus sativus L. Extract and crocin against chronic-stress induced oxidative damage of brain, liver and kidneys in rats","volume":"4","author":"Bandegi","year":"2014","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.neuropharm.2019.107900_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2010.07.033","article-title":"Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease","volume":"216","author":"Barbiero","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2003.12.005","article-title":"Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain","volume":"186","author":"Bashkatova","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2019.107900_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.107900_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","article-title":"Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease","volume":"229","author":"Castro","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.neuropharm.2019.107900_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.drudis.2016.04.005","article-title":"Targeting PRAS40 for multiple diseases","volume":"21","author":"Chong","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2019.107900_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.bjp.0707161","article-title":"Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity","volume":"150","author":"Chong","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3beta dysregulation contributes to Parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and alpha-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2019.107900_bib14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107900_bib15","doi-asserted-by":"crossref","first-page":"e0128651","DOI":"10.1371\/journal.pone.0128651","article-title":"Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson's disease","volume":"10","author":"Dijkstra","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107900_bib16","first-page":"1","article-title":"The protective effects of crocin in the management of neurodegenerative diseases: a review","volume":"7","author":"Farkhondeh","year":"2018","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2019.107900_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cellsig.2016.03.013","article-title":"Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation","volume":"28","author":"Feehan","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2019.107900_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J."},{"key":"10.1016\/j.neuropharm.2019.107900_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fncel.2014.00182","article-title":"miR-7 and miR-153 protect neurons against MPP(+)-induced cell death via upregulation of mTOR pathway","volume":"8","author":"Fragkouli","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107900_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cotox.2018.05.002","article-title":"mTOR\/AMPK signaling in the brain: cell metabolism, proteostasis and survival","volume":"8","author":"Garza-Lombo","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","article-title":"Glycogen synthase kinase-3 beta (GSK-3beta) signaling: implications for Parkinson's disease","volume":"97","author":"Golpich","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","article-title":"Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease","volume":"218","author":"Greene","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.biopsych.2007.04.020","article-title":"Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway","volume":"62","author":"Guo","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107900_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuint.2012.03.010","article-title":"MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation","volume":"60","author":"Hamada","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2019.107900_bib26","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2019.107900_bib27","first-page":"35","article-title":"The effects of crocin on 6-OHDA-induced oxidative\/nitrosative damage and motor behaviour in hemiparkinsonian rats","volume":"23","author":"Hosseini","year":"2016","journal-title":"Malays. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2019.107900_bib28","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1016\/j.neuropharm.2019.107900_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12031-013-0208-0","article-title":"EPO-dependent activation of PI3K\/Akt\/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease","volume":"53","author":"Jia","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107900_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phymed.2013.07.013","article-title":"Crocin improved locomotor function and mechanical behavior in the rat model of contused spinal cord injury through decreasing calcitonin gene related peptide (CGRP)","volume":"21","author":"Karami","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2019.107900_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10787-017-0336-1","article-title":"Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases","volume":"25","author":"Kaur","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107900_bib32","first-page":"59","article-title":"Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats","volume":"14","author":"Khalili","year":"2010","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.neuropharm.2019.107900_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03033861","article-title":"Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency","volume":"14","author":"King","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2011.06.034","article-title":"FoxO1, the transcriptional chief of staff of energy metabolism","volume":"50","author":"Kousteni","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.neuropharm.2019.107900_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.107900_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnmol.2017.00160","article-title":"Downregulation of MicroRNA-193b-3p promotes autophagy and cell survival by targeting TSC1\/mTOR signaling in NSC-34 cells","volume":"10","author":"Li","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107900_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fneur.2013.00033","article-title":"Molecular events underlying Parkinson's disease - an interwoven tapestry","volume":"4","author":"Lim","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2019.107900_bib39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/cbf.3224","article-title":"Serum miR-221 serves as a biomarker for Parkinson's disease","volume":"34","author":"Ma","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.neuropharm.2019.107900_bib40","doi-asserted-by":"crossref","first-page":"13830","DOI":"10.3390\/ijms131113830","article-title":"Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade","volume":"13","author":"Maiese","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2019.107900_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/15376516.2015.1056395","article-title":"Effect of bisphenol A on blood glucose, lipid profile and oxidative stress indices in adult male mice","volume":"25","author":"Moghaddam","year":"2015","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.neuropharm.2019.107900_bib42","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1007\/s11356-017-0842-0","article-title":"Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats","volume":"25","author":"Mohammadzadeh","year":"2018","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.neuropharm.2019.107900_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2010.09.003","article-title":"Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells","volume":"648","author":"Nam","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib44","doi-asserted-by":"crossref","first-page":"22067","DOI":"10.1074\/jbc.M109.033100","article-title":"mTOR\/S6 kinase pathway contributes to astrocyte survival during ischemia","volume":"284","author":"Pastor","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107900_bib45","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.107900_bib46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1590\/0004-282X20160131","article-title":"Effects of crocin on brain oxidative damage and aversive memory in a 6-OHDA model of Parkinson's disease","volume":"74","author":"Rajaei","year":"2016","journal-title":"Arq Neuropsiquiatr."},{"key":"10.1016\/j.neuropharm.2019.107900_bib47","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/j.febslet.2015.10.002","article-title":"Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesis","volume":"589","author":"Rekaik","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2019.107900_bib48","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1002\/jcp.26412","article-title":"Potential neuroprotective effect of androst-5-ene-3beta, 17beta-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model","volume":"233","author":"Salama","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib49","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s11064-018-2644-2","article-title":"Crocin inhibits apoptosis and astrogliosis of Hippocampus neurons against methamphetamine neurotoxicity via antioxidant and anti-inflammatory mechanisms","volume":"43","author":"Shafahi","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2019.107900_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib51","doi-asserted-by":"crossref","first-page":"44701","DOI":"10.1074\/jbc.M206047200","article-title":"Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation","volume":"277","author":"Song","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107900_bib52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.7150\/thno.7026","article-title":"MicroRNAs -the next generation therapeutic targets in human diseases","volume":"3","author":"Srinivasan","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2019.107900_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neurobiolaging.2017.04.001","article-title":"Sirtuin 2 enhances dopaminergic differentiation via the AKT\/GSK-3beta\/beta-catenin pathway","volume":"56","author":"Szego","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuropharm.2019.107900_bib54","first-page":"956","article-title":"Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer\u2019s disease","volume":"43","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2019.107900_bib55","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.1002513","article-title":"Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-beta-signaling pathways regulates the innate inflammatory response","volume":"186","author":"Wang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2019.107900_bib56","doi-asserted-by":"crossref","first-page":"20036","DOI":"10.1074\/jbc.M702376200","article-title":"PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107900_bib57","doi-asserted-by":"crossref","first-page":"48872","DOI":"10.1074\/jbc.M305870200","article-title":"Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53","volume":"278","author":"Watcharasit","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.107900_bib58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/neup.12129","article-title":"MicroRNA-221 targeting PI3-K\/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma","volume":"34","author":"Xie","year":"2014","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuropharm.2019.107900_bib59","first-page":"369","article-title":"[Study of the effect of crocin on rat experimental hyperlipemia and the underlying mechanisms]","volume":"30","author":"Xu","year":"2005","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.neuropharm.2019.107900_bib60","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","article-title":"Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease","volume":"26","author":"Xu","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2019.107900_bib61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pbb.2011.09.002","article-title":"Acetyl-L-carnitine and alpha-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy","volume":"100","author":"Zaitone","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.107900_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuint.2015.07.011","article-title":"Crocin protects PC12 cells against MPP(+)-induced injury through inhibition of mitochondrial dysfunction and ER stress","volume":"89","author":"Zhang","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2019.107900_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2006.09.019","article-title":"S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt","volume":"24","author":"Zhang","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2019.107900_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/toxsci\/kfu211","article-title":"Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1\/eIF4E pathways, leading to neuronal apoptosis","volume":"143","author":"Zhou","year":"2015","journal-title":"Toxicol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081930471X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081930471X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T13:53:31Z","timestamp":1578405211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081930471X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":64,"alternative-id":["S002839081930471X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107900","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107900"}}